High voltage-gated calcium channels enable calcium entry into cells in response to membrane depolarization. Association of the auxiliary ␤-subunit to the ␣-interaction-domain in the pore-forming ␣ 1 -subunit is required to form functional channels. The ␤-subunit belongs to the membrane-associated guanylate kinase class of scaffolding proteins containing a Src homology 3 and a guanylate kinase domain. Although the latter is responsible for the high affinity binding to the ␣-interaction domain, the functional significance of the Src homology 3 domain remains elusive. Here, we show that injection of isolated ␤-subunit Src homology 3 domain into Xenopus laevis oocytes expressing the ␣ 1 -subunit reduces the number of channels in the plasma membrane. This effect is reverted by coexpressing ␣ 1 with a dominant-negative mutant of dynamin, a GTPase involved in receptor-mediated endocytosis. Full-length ␤-subunit also down-regulates voltage-gated calcium channels but only when lacking the ␣-interaction domain. Moreover, isolated Src homology 3 domain and the full-length ␤-subunit were found to interact in vitro with dynamin and to internalize the distantly related Shaker potassium channel. These results demonstrate that the ␤-subunit regulates the turnover of voltagegated calcium channels and other proteins in the cell membrane. This effect is mediated by dynamin and depends on the association state of the ␤-subunit to the ␣ 1 -pore-forming subunit. Our findings define a novel function for the ␤-subunit through its Src homology 3 domain and establish a link between voltage-gated calcium channel activity and the cell endocytic machinery. 3 The abbreviations used are: VGCC, voltage-gated calcium channel; AID, ␣-interaction domain; Ca V ␤, ␤-subunit of VGCCs; Ca V ␣ 1 , pore-forming ␣-subunit of VGCCs; Ca V 1.2, cardiac isoform of the ␣-subunit of VGCCs; SH3, Src-homology 3 domain; GK, guanylate kinase domain; ␤ 2a -SH3, Srchomology 3 domain from ␤ 2a isoform; GST, glutathione S-transferase; GST-Dyn 829 -842 , dynamin peptide encompassing residues 829 -842; Q on , charge movement; PRD, proline-rich domain; WT, wild type; HA, hemagglutinin; pC, picocoulomb; cps, counts/second.
Cellular processes including muscle contraction, endocrine secretion, synaptic transmission, and gene expression (1), depend on the regulated influx of calcium through voltagegated calcium channels (VGCCs). 3 VGCCs are multiprotein complexes containing a pore-forming subunit (Ca V ␣ 1 ) and a variable number of auxiliary subunits. Association of the auxiliary ␤-subunit (Ca V ␤) to a site shared by all Ca V ␣ 1 , the so-called ␣-interaction domain (AID), is mandatory to form a fully functional VGCC. Homology modeling (2) and the recent high resolution crystal structures of three Ca V ␤ isoforms (3) (4) (5) identified Ca V ␤ as a novel member of the membrane-associated guanylate kinase class of scaffolding proteins containing a Src homology 3 (SH3) and a guanylate kinase (GK) domain (Fig.  1A) . As shown by the crystal structure of Ca V ␤ complexed to AID, the Ca V ␤-GK binds to the AID, whereas Ca V ␤-SH3 interacts with GK. Although SH3 domains are known to mediate protein-protein interactions by binding to proline-rich motifs in ligand proteins (6) , no interactions mediated by the Ca V ␤-SH3 have been described yet. Moreover, the functional integrity of Ca V ␤-SH3 domain is uncertain since the residues homologous to the ones critical for binding PXXP motifs in canonical SH3 modules are occluded in the crystal structure of Ca V ␤. Intriguingly, canine and human cardiac cells express splicing variants encoding short versions of the Ca V ␤ that only encompass the variable N-terminal region and the SH3 domain (7, 8) (Fig. 1A, V1 and C1, respectively).
Here, we studied the effect of isolated Ca V ␤-SH3 on calcium channel function and expression. The SH3 domain of the rat ␤ 2a isoform of Ca V ␤ (␤ 2a -SH3) was expressed in bacteria, purified, and injected into Xenopus oocytes expressing the cardiac Ca V ␣ 1 (Ca V 1.2) subunit isoform. We found that the ␤ 2a -SH3 induces removal of channels from the plasma membrane in a dynamin-dependent fashion. This function is preserved by fulllength Ca V ␤ in the absence of Ca V ␣ 1 subunit or when binding to it is disrupted by deleting the AID site. Our results define a novel interaction and outline a new function for the calcium channel ␤-subunit. 
EXPERIMENTAL PROCEDURES
Recombinant Proteins-The cDNA encoding the SH3 domain of the rat ␤ 2a isoform (Swiss-Prot entry:Q8VGC3) encompassing residues 24 -136 was subcloned between BamHI and EcoRI restriction sites by conventional PCR methods into pRSETB vector (Invitrogen) to introduce a polyhistidine tag at the N-terminal. The molecular mass predicted by the amino acid sequence of the Ca V ␤ 2a -SH3 His-tagged protein is 16.7 kDa. The His-tagged Ca V ␤ 2a -SH3 was expressed in BL-21 (DE-3) E. coli bacteria by a 2-h induction with 0.5 mM isopropyl-␤-D-thiogalactopyranoside at 37°C. Cells were harvested by centrifugation, flash-frozen, and stored until use at Ϫ80°C. Right before protein purification, the cells were resuspended in phosphate buffer (50 mM sodium phosphate buffer and 300 mM NaCl, pH 7.0) containing EDTA-free protease inhibitor mixture (Roche Applied Science) and disrupted by ultrasonication. After centrifugation, the protein was purified from the cleared cell lysate by using a cobalt-based metal affinity chromatogra-FIGURE 1. ␤ 2a -SH3 reduces charge movement in Xenopus oocytes expressing Ca V 1.2. A, Ca V ␤ domains. V1, V2, and V3 denote variable regions, and C1 and C2 denote conserved SH3-and GK-like domains, respectively. Numbers refer to the amino acid sequence in the ␤ 2a rat isoform used in this study. B, size exclusion chromatography profile of purified ␤ 2a -SH3 domain and molecular mass calibration curve on Superdex 200 10/30 column (GE Healthcare Life Sciences). 1 denotes void volume, and 2, 3, and 4 denote the elution volume of albumin (67 kDa), ovalbumin (43 kDa), and ribonuclease A (13.7 kDa), respectively. The inset shows a SDS-PAGE performed on purified ␤ 2a -SH3 with numbers corresponding to the molecular mass of standards in kDa. MW, molecular weight. C, average Q on from Ca V 1.2-expressing oocytes before (132.6 Ϯ 11.6 pC, n ϭ 18) and after ␤ 2a -SH3 (26.0 Ϯ 3.8 pC, n ϭ 25) or buffer injection (123.6 Ϯ 10.5 pC, n ϭ 22) as control. Q on was measured by integrating gating current during a step near I Ba reversal potential as shown in the inset. Voltage near I Ba reversal potential was determined empirically by stepping to several potentials in 2-mV increments. D, time course of the ␤ 2a -SH3-induced decrease in Q on in Ca V 1.2-expressing Xenopus oocytes. Each point corresponds to the average of Q on measured as in panel C for several oocytes recorded at different times following the injection of ␤ 2a -SH3. Averages for each time point include measurements up to 30 min before the indicated time, and t ϭ zero corresponds to the average Q on from non-injected oocytes. The data were fitted to Q on ϭ Q o (exp[Ϫt/]), where Q o is the estimated Q on at time 0 in pC (108 pC), Q min is the residual Q on (25.7 pC), and is the time constant in hours (0.90 h). E, average current-voltage plot normalized by Q on from Ca V 1.2-expressing oocytes before protein injection (E) and after ␤ 2a-SH3 (F) or Ca V ␤2a (ࡗ) injection. F, representative gating currents traces and voltage dependence of Q on from Ca V 1.2-expressing oocytes before (E) and after ␤ 2a -SH3 injection (F) during 20-ms voltage pulses from Ϫ80 mV to ϩ40 mV in 5-mV increments from a holding potential of Ϫ90 mV recorded in 2 mM external Co 2ϩ . G, representative gating currents traces and time dependence of Q on from Ca V 1.2-expressing oocytes before (E) and after ␤ 2a -SH3 injection (F) during pulses to ϩ40 mV of variable duration (0.5-12.5 ms in 0.5-ms increments) from a holding of Ϫ90 mV. Proteins were injected 1-5 h before recordings. See details in supplemental Tables S1 and S2. phy (Talon, BD Biosciences) according to the manufacturer's instructions followed by size-exclusion chromatography onto a Superdex TM S-200 column 26/60 (GE Healthcare Life Sciences) pre-equilibrated with buffer containing 20 mM Tris buffer, 300 mM NaCl, 1 mM EDTA, pH 8.0. The fractions containing the protein were pooled, concentrated up to 1-2 mg/ml by centrifugation using Amicon Ultra tubes with 10,000 molecular weight cut-off (Millipore), aliquoted, flash-frozen, and stored at Ϫ80°C until use. The full-length Ca V ␤ 2a was prepared as described (9) . The apparent molecular mass of His-tagged Ca V ␤ 2a -SH3 determined from the size exclusion chromatography calibration curve was obtained from the partition coefficient value (K av ) calculated from its elution volume as described
and V e is the elution volume of the protein; V o is the void volume of the column calibrated with blue dextran, and V t is the total bed volume. A set of globular protein standards was used as indicated in Fig. 1 . Mass spectrometry analysis was performed in the mass spectrometry laboratory, Zentrums Pharmakologie und Toxikologie, Medizinische Hochschule Hannover. The protein was digested by trypsin, and the peptides were analyzed in an Ultraflex matrix-assisted laser desorption/ionization-time of flight/time of flight mass spectrometer (Bruker Daltonics).
The GST-Dyn 829 -842 peptide was prepared as follows. Two overlapping oligonucleotides were designed according to the dynamin sequence (Swiss-Prot entry: Q05193) to encode the peptide sequence from residues 829 -842 ( 829 PPQVPSRPN-RAPPG 842 ). After annealing, the oligonucleotides were ligated into pGEX vector (GE Healthcare Life Sciences) to fuse a GST at the N-terminal (GST-Dyn 829 -842 peptide). The GST alone and GST-Dyn 829 -842 peptide were expressed in bacteria and purified as described (10) . Dynamin mutation and Ca V 1.2 ⌬ AID deletion were done by standard overlapping PCR using complementary oligonucleotides.
Binding Assay-Pull-down assays using His-tagged Ca V ␤ 2aderivatives as baits were performed as described (10) . Briefly, His-Ca V ␤ 2a derivatives were coupled to cobalt-based agarose for 1 h at 4°C and incubated for another hour with precleared tsA201 cell extract obtained 24 -48 h after transfection with dynamin or with YFP-Ca V 1.2 expression vector. The beads were pelleted and washed five times, and bound fractions were eluted with SDS-PAGE loading buffer and resolved on SDS-PAGE. In the binding assays to dynamin, the gel was transferred to nitrocellulose membrane and subjected to immunoblot analysis using anti dynamin antibody (BD Biosciences). Binding to YFP-Ca V 1.2 was visualized by fluorescence scanning using a Typhoon imager (GE Healthcare Life Sciences). . C, average Q on measured from Xenopus oocytes expressing Ca V 1.2 treated with 500 nM bafilomycin for 24 h before (80.9 Ϯ 9.8 pC, n ϭ 8) and after ␤ 2a -SH3 injection (28.9 Ϯ 7.3 pC, n ϭ 7). In both cases, the reduction in Q on following ␤ 2a -SH3 injection is significant (t test, p Ͻ 0.01). Xenopus Oocytes Preparation, Injection, and Electrophysiological Recordings-Xenopus laevis oocytes were prepared, injected, and maintained as in a previous report (10) . All capped cRNAs were synthesized using the MESSAGE-machine (Ambion, Austin TX), resuspended in 10 l of water and stored in 2-l aliquots at Ϫ80°C until use. The Ca V 1.2-subunit used in this study bears a deletion of 60 amino acids at the N-terminal end that increase expression (11) . Electrophysiological recordings on Ca V 1.2-expressing oocytes were performed 2-5 h after protein injection (50 nl of the protein stock solution, 1-2 mg/ml/oocyte) and 5-7 days after cRNA injection using the cut-open oocyte technique with a CA-1B amplifier (Dagan Corp., Minneapolis, MN) as described (9) . The external solution contained (in mM) 10 Ba 2ϩ , 96 n-methylglucamine, and 10 HEPES pH 7.0, and the internal solution contained (in mM) 120 n-methylglucamine, 10 EGTA, and 10 HEPES, pH 7.0. Data acquisition and analysis were performed using the pCLAMP system and software (Axon Instruments Inc., Foster City, CA). Currents were filtered at 2 kHz and digitized at 10 kHz. Linear components were eliminated by P/-4 prepulse protocol. The normalized charge movement-voltage plot and the average current-voltage plot were obtained as described (12) using a CA-1B amplifier (Dagan). Currents were filtered at 1 kHz and digitized at 20 kHz. Ionic currents mediated by Shaker potassium channel were recorded 1 day after cRNA injection with two-electrode voltage clamp technique using a Dagan TEV 200A or Warner OC725A and filtered at 10 kHz. For the bafilomycin treatment, oocytes were incubated with 500 nM bafilomycin A 1 (Sigma) 24 h prior to protein injection (9) . The Shaker channel used, Sh IR (inactivation removed), bears an N-terminal deletion that removes fast inactivation (13) . Surface Expression Measurements in Xenopus Oocytes-Surface expression of Ca V 1.2 channels bearing the HA epitope (Ca V 1.2-HA) was measured by immunoassay as described (9) . Briefly, 5-7 days after Ca V 1.2 RNA injection, oocytes were separated in two groups: for electrophysiological recordings and for immunoassay. Oocytes were incubated in blocking buffer containing 1% bovine serum albumin followed by incubation with 1 g/ml rat monoclonal anti-HA antibody (3F10, Roche Applied Science). After washing, oocytes were incubated with horseradish peroxidasecoupled secondary antibody (goat anti-rat FAB fragments, Jackson ImmunoResearch) and extensively washed, and individual oocytes were placed in 50 l of SuperSignal 
RESULTS
␤ 2a -SH3 Reduces the Number of Channels Expressed in the Plasma Membrane-The purified SH3 domain of the Ca V ␤ 2a with an expected molecular mass of 16.7 kDa elutes as a monodisperse peak from a size exclusion chromatography (Fig. 1B) . The size exclusion chromatography calibration curve yielded an apparent molecular mass of 20.8 kDa that is compatible with a monomeric conformation of the protein. Mass spectrometry analysis on the purified ␤ 2a -SH3 confirmed its identity (data not shown). ␤ 2a -SH3 was injected in Xenopus oocytes expressing Ca V 1.2, and gating and ionic currents were measured using the cut-open oocyte voltage clamp technique. Injection of ␤ 2a -SH3 into oocytes causes a dramatic decrease in charge movement (Q on , Fig. 1C ) that develops with a time constant of 0.9 h (Fig. 1D ). Q on stems from the conformational changes leading to channel opening (14) and, thus, it is proportional to the number of channels. Since decrease in Q on proceeds without changes in the voltage or time dependence (Fig. 1, E-G) , it likely reflects a reduction in the number of channels in the cell surface (9) . In contrast, injection of full-length Ca V ␤, does modify channel gating as expected (15) (Fig. 1E) . We corroborated that the drop of Q on upon ␤ 2a -SH3 injection stems from a decrease in the number of channels in the plasma membrane by immunoassay (9) . Channel surface expression was measured in oocytes expressing HA-tagged Ca V 1.2 channels and compared with Q on measurements on the same group of oocytes as shown in Fig. 2A .
Impaired assembly and forward trafficking or enhanced backward trafficking may be responsible for the reduction in the number of channels expressed in the plasma membrane upon ␤ 2a -SH3 injection. To discriminate between these two possibilities, we examined the effect of ␤ 2a -SH3 when incorporation of new proteins into the plasma membrane was inhibited by bafilomycin. We have previously shown that indeed, bafilomycin treatment interrupts incorporation of new Ca V 1.2 channels in oocytes and causes a net reduction of channel density due to constitutive turnover (9) . Injection of ␤ 2a -SH3 in bafilomycin-treated oocytes resulted in 35% reduction in Qon (Fig. 2C ) that compares with the 29% observed in control conditions (Fig. 2B) . Thus, down-regulation induced by ␤ 2a -SH3 was not prevented by bafilomycin, indicating that this domain interferes with the backward trafficking rather than with the incorporation of newly formed channels.
␤ 2a -SH3-induced Reduction of Q on Depends on Dynamin-Removal of membrane proteins from the surface implicates endocytosis. Several SH3-containing proteins participate in the regulation of this process by associating with dynamin, a GTPase that excises endocytic vesicles from the plasma membrane (16 -19) . The proline-rich domain (PRD) of dynamin binds to SH3 domains in the partner protein, and this interaction recruits dynamin to the plasma membrane. Moreover, endocytosis of ion channels and receptors through a dynamindependent process has been reported (20 -22) . Therefore, we investigated the potential role of dynamin in ␤ 2a -SH3 induced channel internalization. We first verified the presence of endogenous dynamin in Xenopus oocytes by Western blot analysis using anti-dynamin antibody and detected a protein of molecular mass similar to a heterologously expressed HA-tagged dynamin I (Fig. 3A) . Coexpressing Ca V 1.2 with dynamin did not have a direct impact on channel expression, and ␤ 2a -SH3 induced reduction of Q on was equivalent (com- 
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pare Fig. 1C and 3B ). We then examined the effect of expressing a dominant-negative mutant of dynamin lacking GTPase activity that inhibits endocytosis (dynamin K44A) (23) . Co-expression with dynamin K44A reduced oocyte survival rate and yielded smaller Q on than Ca V 1.2 alone or with dynamin WT. Although the causes for these changes are unclear, we still observed that ␤ 2a -SH3-induced reduction of Q on was blunted by expression of dynamin K44A (Fig. 3C) .
To further test the role of dynamin, we fused a 14-amino-acid residue peptide spanning the proline-rich region of dynamin I to GST protein to produce GST-Dyn 829 -842 peptide. This peptide is known to disrupt the interaction between dynamin and SH-3 domains and to inhibit endocytosis in synaptic vesicles (24, 25) . Fig. 3D shows that preincubation of ␤ 2a -SH3 with GST-Dyn 829 -842 peptide, but not with GST alone, inhibits its potency to reduce Q on . Furthermore, ␤ 2a -SH3 binds in vitro to dynamin ( Fig. 4A ) and, consistently with the electrophysiological data, this binding is partially blocked by GST-Dyn 829 -842 peptide but not by GST (Fig. 4B) . We tested the ability of ␤ 2a -SH3 to bind to the full-length channel. Using a similar pull-down assay, we did not observe binding of ␤ 2a -SH3 to Ca V 1.2 fused to the yellow fluorescent protein (YFP-Ca V 1.2; Fig. 4C ). In contrast and as expected, Ca V ␤ and the functional core of Ca V ␤ (26) encompassing the SH3 and GK domains (Fig. 1A, C1-C2) bound to the channel.
␤ 2a -SH3 and Full-length Ca V ␤ 2a Down-regulate the Distantly Related Shaker Potassium Channel Expressed in Xenopus Oocytes-Because ␤ 2a -SH3 promotes channel internalization without binding to the channel protein, we examined the effect of ␤ 2a -SH3 onto the distantly related Shaker potassium channel that lacks binding activity to the Ca V ␤-subunit (27) . Injection of ␤ 2a -SH3 to oocytes expressing the Shaker channel resulted in no changes in channel gating (supplemental Fig. S1 ), but ionic currents were reduced by ϳ60% 1 h after protein injection (Fig.  5A ). This current reduction was also partially blocked by preincubation of ␤ 2a -SH3 with GST-Dyn 829 -842 peptide but not with GST ( Fig. 5B ). Full-length Ca V ␤ 2a preserves the ability of ␤ 2a -SH3 to down-regulate Shaker channels expressed in oocytes. Ca V ␤ 2a reduced ionic currents to a similar degree as ␤ 2a -SH3 (Fig. 5C ) without changes in the voltage dependence (supplemental Fig. S2 ). This current decrease was also antagonized by GST-Dyn 829 -842 peptide. Moreover, Ca V ␤ 2a bound in vitro to dynamin, and this interaction was inhibited by GST-Dyn 829 -842 peptide (Fig. 5D ). These results indicate that Ca V ␤ still acts through the dynamin-dependent endocytic pathway.
Full-length Ca V ␤ 2a Reduces the Number of Plasma Membrane Ca V 1.2 Channels Lacking the AID but Not WT Channels-A corollary from the above results is that free Ca V ␤ may also be able to reduce surface expression of Ca V 1.2 channels when the Ca V ␣ 1 -Ca V ␤ primary interaction site is disrupted. To test this possibility, we deleted the AID site of Ca V 1.2 (residues 459 -475) to obtain Ca V 1.2-⌬AID channels. This mutated channel yields gating currents that, with respect to their voltage and time dependence, are indistinguishable from wild type Ca V 1.2 (Fig. 6, A and B) , but as expected, Ca V ␤ 2a loses its ability to potentiate ionic currents (Fig. 6C ). As recently corroborated by chemiluminescent enzyme immunoassay (9), surface expression of Ca V 1.2 channels in oocytes is not altered by injection of Ca V ␤2a protein (Fig. 6D ). In contrast, in oocytes expressing Ca V 1.2-⌬AID, injection of Ca V ␤ 2a reduces Q on to the same extent as did ␤ 2a -SH3 in oocytes expressing wild type Ca V 1.2 (Fig. 6E) . To further prove that channels lacking the AID are indeed expressed in the plasma membrane and that Ca V ␤ decreases the number of channels at the cell surface, we performed the surface expression assay with Ca V 1.2-⌬AID HA-tagged channels. Ca V ␤ 2a injection decreased Q on and chemiluminescence signal in Ca V 1.2-⌬AID-expressing oocytes (Fig. 6F ).
DISCUSSION
We here show that the SH3 domain of the ␤-subunit of the voltage-gated calcium channels promotes internalization of membrane proteins in a dynamin-dependent manner. In addition, we found that Ca V ␤-SH3 binds in vitro to dynamin and, since this association is inhibited by GST-Dyn 829 -842 peptide, we propose that this interaction is mediated by the PRD of dynamin. Nevertheless, simulated docking predictions indicate that Ca V ␤-SH3 is unlikely to interact with PXXP motifs unless a considerable structural rearrangement occurs (4). The dynamin PRD-Ca V ␤-SH3 interaction may be mediated by noncanonical PXXP binding residues in Ca V ␤-SH3 or, alternatively, exposition of canonical residues may be tunable by a yet unknown regulatory protein or event. The interaction between recombinant ␤ 2a -SH3 and dynamin may reflect an in vivo phenomenon given that a SH3-only form of the Ca V ␤ protein is expressed in cardiac cells (8) .
Binding of Ca V ␤-SH3 to the protein being sequestered is not required since no interaction between the ␤ 2a -SH3 and the whole Ca V 1.2 channel was observed, and certainly, no association occurs with the Shaker channel. Ca V ␤-SH3 has been reported to associate only with isolated regions or truncated Ca V ␣ 1 channels (28, 29) . Thus, it is conceivable that other cytoplasmic regions within the whole channel hinder this association.
In the presence of the full-length Ca V ␤-subunit, calcium channels lacking the AID site, but not WT channels, are down- FIGURE 7 . Model for Ca V ␤ and dynamin interaction. The schematic depicts that association of Ca V ␤ to Ca V 1.2 masks the SH3-module. Upon dissociation from Ca V ␣ 1 , the SH3 domain becomes available to interact with dynamin, leading to down-regulation of calcium currents through endocytosis. How the interaction with Ca V ␤-SH3 recruits dynamin to its anchor site remains to be investigated. regulated, as though binding to Ca V ␤ prevents the channel complex to be internalized. Since association of the Ca V ␤ to VGCCs ensures normal channel activity, this would constitute an efficient quality control mechanism in which the same protein ensures functional fitness and survival of the channel in the plasma membrane ( Fig. 7) . Our recent finding that the Ca V ␣ 1 -Ca V ␤ interaction is reversible at the level of the plasma membrane (9) supports this mechanism. The ability of this auxiliary subunit to influence internalization of other membrane proteins anticipates that replacement of complete signal transduction assemblies may be triggered by the presence of free Ca V ␤. Although the whole picture is certainly still incomplete, our findings outline a novel signaling pathway for the regulation of intracellular calcium concentration.
